Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −212,967−100.0% | Sold out | Holders |
| Q3 2023 | 212,967 | $3.09M | <0.1% | −152,205−41.7% | Reduced | Holders |
| Q2 2023 | 365,172 | $7.64M | <0.1% | −119,494−24.7% | Reduced | Holders |
| Q1 2023 | 484,666 | $10.2M | <0.1% | +148,670+44.2% | Added | Holders |
| Q4 2022 | 335,996 | $8.55M | <0.1% | +1,033+0.3% | Added | Holders |
| Q3 2022 | 334,963 | $8.05M | <0.1% | +20,049+6.4% | Added | Holders |
| Q2 2022 | 314,914 | $6.06M | <0.1% | +21,565+7.4% | Added | Holders |
| Q1 2022 | 293,349 | $5.10M | <0.1% | +5,297+1.8% | Added | Holders |
| Q4 2021 | 288,052 | $6.30M | <0.1% | −2,792−1.0% | Reduced | Holders |
| Q3 2021 | 290,844 | $5.56M | <0.1% | −3,765−1.3% | Reduced | Holders |
| Q2 2021 | 294,609 | $5.06M | <0.1% | +294,609 | New | Holders |